Treace Medical Concepts (TMCI) Return on Capital Employed (2021 - 2026)

Treace Medical Concepts has reported Return on Capital Employed for 6 years, with the latest figure at 36.47% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed fell 713.0% year-over-year to 36.47%; the trailing twelve-month figure through Mar 2026 stood at 36.47% (down 713.0% YoY), and the FY2025 full-year result was 31.27%, down 336.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 36.47%, down from 33.23% in the prior quarter.
• The five-year high for Return on Capital Employed was 18.09% in Q1 2022, with the low at 36.47% in Q1 2026.
• Historically, Return on Capital Employed has averaged 27.73% across 5 years, with a median of 28.27% in 2024.
• Annual changes were most pronounced in 2022 — Return on Capital Employed plunged 2173 bps — and 2025, when it soared 503 bps.
• Treace Medical Concepts' Return on Capital Employed stood at 27.33% in 2022, then advanced by 6 bps to 25.57% in 2023, then decreased by 21 bps to 30.92% in 2024, then declined by 7 bps to 33.23% in 2025, then fell by 10 bps to 36.47% in 2026.
• The last three Return on Capital Employed figures came in at 36.47% (Q1 2026), 33.23% (Q4 2025), and 30.16% (Q3 2025), per Business Quant data.